BeStock  

Phreesia PHR

US equityMarket cap rank #3565Health Information Services
$10.50 +$0.25 (+2.44%)
Pre-market · Oct 8, 9:10 am ET · After hours $10.50 0.00%
Open$10.25
Prev close$10.25
Day range$10.21 – $10.55
Volume595.9K
Market cap$651.74M
P/E (TTM)58.3
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership98.7%-0.30 pts vs. prior quarter
Institutions holding277+0 vs. prior quarter
Insider trades (recent)31 buys / 19 sellsNet buying
Short interest5.02% of floatDays to cover 4.2 · as of 15 Sep 2026
Short-sale volume share23.6%5-day average of daily volume

Short-sale volume as % of daily volume

19%22%26%29%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$46.3K (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

+$259.3KSuper−$305.6KBig−$302.8KMid−$107.8KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 40.2% of shares outstanding.

Largest holders

  • Pale Fire Capital SE14.38%
  • BlackRock11.31%
  • AQR Capital Management4.95%
  • Vanguard Portfolio Management, LLC4.81%
  • Vanguard Capital Management, LLC4.76%
  • Acadian Asset Management LLC2.59%
  • State Street Global Advisors2.54%
  • T. Rowe Price Group, Inc.2.26%

By investor type

  • Mutual Fund59.80%
  • Hedge Fund15.42%
  • VC/PE Fund14.38%
  • Individual/Insider6.29%
  • Private Company3.94%
  • Public Company3.13%
  • Insurance Company1.12%
  • Government Pension Fund0.68%

Reported short interest has fallen from 5.61% to 5.02% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
David Linetsky Individual/Insider 2026/Q3 +346,685 0.7%
Evan Roberts Individual/Insider 2026/Q3 +332,524 1.7%
Balaji Gandhi Individual/Insider 2026/Q3 +329,478 0.6%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +153,119 1.0%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,316,038 2.3%
AQR Capital Management Hedge Fund 2026/Q3 +1,255,219 5.0%
BlackRock Mutual Fund 2026/Q3 +1,099,363 11.3%
Nordea Investment Management AB Mutual Fund 2026/Q3 +784,279 1.3%
Acadian Asset Management LLC Mutual Fund 2026/Q3 +576,566 2.6%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +512,955 0.8%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +484,115 0.8%
Eaton Vance Management Mutual Fund 2026/Q3 +463,217 0.8%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +280,841 1.4%
Pale Fire Capital SE VC/PE Fund 2026/Q3 +275,000 14.4%
Millennium Management LLC Hedge Fund 2026/Q3 +256,111 0.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
20 Sep 2026 Allison Hoffman General Counsel Automatic Disposition -6,662 $10.08 48,686
17 Sep 2026 Allison Hoffman General Counsel Sale to Issuer -7,401 $10.42 48,686
17 Sep 2026 Evan Roberts Co-Founder & COO Sale to Issuer -4,476 $10.42 1,038,138
17 Sep 2026 Amy VanDuyn Officer Sale to Issuer -2,876 $10.42 260,521
17 Sep 2026 David Linetsky Senior Vice President of Life Sciences Sale to Issuer -4,794 $10.42 441,961
13 Sep 2026 Allison Hoffman General Counsel Other Acquisition +14,063 – 62,748
13 Sep 2026 Evan Roberts Co-Founder & COO Other Acquisition +8,113 – 1,042,614
13 Sep 2026 Amy VanDuyn Officer Other Acquisition +6,490 – 263,397
13 Sep 2026 David Linetsky Senior Vice President of Life Sciences Other Acquisition +8,816 – 446,755
31 Aug 2026 Allison Hoffman General Counsel Other Acquisition +108,000 – 205,660
31 Aug 2026 Allison Hoffman General Counsel Other Derivative Acquisition +85,000 – 85,000
31 Aug 2026 Balaji Gandhi Chief Financial Officer Other Acquisition +192,000 – 348,931
31 Aug 2026 Balaji Gandhi Chief Financial Officer Other Derivative Acquisition +155,000 – 155,000
31 Aug 2026 Chaim Indig Chief Executive Officer Other Acquisition +500,000 – 771,971
31 Aug 2026 Chaim Indig Chief Executive Officer Other Derivative Acquisition +400,000 – 400,000
31 Aug 2026 Evan Roberts Co-Founder & COO Other Acquisition +192,000 – 1,034,501
31 Aug 2026 Evan Roberts Co-Founder & COO Other Derivative Acquisition +155,000 – 155,000
31 Aug 2026 Amy VanDuyn Officer Other Acquisition +88,000 – 256,907
31 Aug 2026 Amy VanDuyn Officer Other Derivative Acquisition +67,500 – 67,500
31 Aug 2026 David Linetsky Senior Vice President of Life Sciences Other Acquisition +202,000 – 437,939

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 3,114,156 5.0% 4.2
31 Aug 2026 2,926,271 4.7% 3.4
14 Aug 2026 2,705,925 4.4% 3.9
31 Jul 2026 2,908,789 4.7% 4.2
15 Jul 2026 3,520,033 5.7% 4.4
30 Jun 2026 3,469,842 5.6% 2.5

Discussion

No comments yet — be the first to weigh in on PHR.

Leave a comment

Scroll to Top